Swedish biotech company near breakthrough in treatment against covid-19 – looking for investors
April 16, 2020
Researchers at the biotech company Amniotics in Lund has developed a lung specific stem cell for treatment of covid-19. The market for treating lung- and airway diseases is valued at 47 billion Euro.
– At present, we are working day and night to finish our process validation. We are in close contact with the Swedish Medical Products Agency (Läkemedelsverket) to initiate a clinical trial and we hope to soon be able to send an application, says Kåre Engkilde, CEO at Amniotics.